RARRES2 and type 2 diabetes mellitus: In the present study, alterations of serum visfatin, resistin and chemerin were studied in T2DM patients coexisting with clinical and subclinical thyroid dysfunctions, and their associations with thyroid hormones and inflammatory markers were evaluated.